Critical Care

, 16:P199 | Cite as

What matters during a hypotensive episode: fluids, vasopressors, or both?

  • J Lee
  • R Kothari
  • JA Ladapo
  • DJ Scott
  • LA Celi
Poster presentation


The objective of this retrospective study was to investigate the relationships between fluid and vasopressor interventions and patient outcomes. In intensive care, it is imperative to resolve hypotensive episodes (HEs) in a timely manner in order to minimize end-organ damage. The current clinical practice is first to attempt fluid resuscitation and then to follow with vasopressor therapy if fluid resuscitation is unsuccessful. However, the effects of fluid and vasopressor interventions on patient outcomes have not been clearly established.


Hypotension was defined as MAP below 60 mmHg. The primary outcome was in-hospital mortality. Secondary outcomes included ICU LOS, HE duration, Hypotension Severity Index (HSI) (MAP curve area below 60 mmHg during the HE), and rise in serum creatinine. The patient cohort included patients in the MIMIC-II database [1] who experienced a single HE. Multivariate logistic regression and propensity score analysis were employed. Sensitivity analyses were conducted in subpopulations stratified by treatment type and diagnosis.


A total of 3,163 patients in MIMIC-II met the inclusion criteria. The multivariate regression results showed that fluid resuscitation was significantly associated with shorter ICU LOS (OR = 0.71, P = 0.007) and greater HSI (OR = 1.26, P = 0.04). Vasopressor administration significantly decreased HE duration (OR = 0.29, P < 0.001) and HSI (OR = 0.72, P = 0.002) but was correlated with increased in-hospital mortality risk (OR = 2.86, P < 0.001) (even after propensity adjustment; OR = 2.44, P < 0.001), prolonged ICU LOS (OR = 1.29, P = 0.04), and rise in serum creatinine (OR = 1.44, P = 0.002). Sensitivity analyses in treatment-specific and diagnosis-specific subpopulations corroborated the relationship between vasopressors and increased in-hospital mortality.


Regarding the relationship between vasopressor therapy and in-hospital mortality, similar findings have been reported in previous studies analyzing sepsis [2], cardiac surgery [3], and heart failure [4]. We speculate that benefits of vasopressor use may be restricted to subsets of patients with specific conditions. This study illustrates the utility of electronic medical records in research when randomized controlled trials are difficult to conduct.


  1. 1.
    Saeed M, et al.: Crit Care Med. 2011, 39: 952-960. 10.1097/CCM.0b013e31820a92c6PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Dunser M, et al.: Crit Care. 2009, 13: R181. 10.1186/cc8167PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Shahin J, et al.: Crit Care. 2011, 15: R162. 10.1186/cc10302PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Thackraya S, et al.: Eur J Heart Fail. 2002, 4: 515-529. 10.1016/S1388-9842(02)00041-7CrossRefGoogle Scholar

Copyright information

© Lee et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors and Affiliations

  • J Lee
    • 1
  • R Kothari
    • 2
  • JA Ladapo
    • 3
  • DJ Scott
    • 1
  • LA Celi
    • 1
  1. 1.Massachusetts Institute of TechnologyCambridgeUSA
  2. 2.Mount Sinai School of MedicineNew York CityUSA
  3. 3.New York University School of MedicineNew York CityUSA

Personalised recommendations